Search Results - "Mowry, Ellen M"

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria by Thompson, Alan J, Banwell, Brenda L, Barkhof, Frederik, Carroll, William M, Coetzee, Timothy, Comi, Giancarlo, Correale, Jorge, Fazekas, Franz, Filippi, Massimo, Freedman, Mark S, Fujihara, Kazuo, Galetta, Steven L, Hartung, Hans Peter, Kappos, Ludwig, Lublin, Fred D, Marrie, Ruth Ann, Miller, Aaron E, Miller, David H, Montalban, Xavier, Mowry, Ellen M, Sorensen, Per Soelberg, Tintoré, Mar, Traboulsee, Anthony L, Trojano, Maria, Uitdehaag, Bernard M J, Vukusic, Sandra, Waubant, Emmanuelle, Weinshenker, Brian G, Reingold, Stephen C, Cohen, Jeffrey A

“…The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. Scientific advances in the past 7 years…”
Get full text

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis by Sotirchos, Elias S, Bhargava, Pavan, Eckstein, Christopher, Van Haren, Keith, Baynes, Moira, Ntranos, Achilles, Gocke, Anne, Steinman, Lawrence, Mowry, Ellen M, Calabresi, Peter A

“…OBJECTIVE:To study the safety profile and characterize the immunologic effects of high- vs low-dose cholecalciferol supplementation in patients with multiple…”
Get full text

Unsupervised MR harmonization by learning disentangled representations using information bottleneck theory by Zuo, Lianrui, Dewey, Blake E., Liu, Yihao, He, Yufan, Newsome, Scott D., Mowry, Ellen M., Resnick, Susan M., Prince, Jerry L., Carass, Aaron

“…•Unsupervised MR harmonization without traveling subjects.•Unified latent space for MR contrast synthesis.•A novel framework for disentangling contrast and…”
Get full text

Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators by Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.

“…Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in…”
Get full text

The influence of nutritional factors on the prognosis of multiple sclerosis by von Geldern, Gloria, Mowry, Ellen M.

“…In this Review, von Geldern and Mowry discuss the potential effects of vitamin D and other dietary components on the disease course of multiple sclerosis (MS)…”
Get full text

Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy by Gadani, Sachin P., Reyes-Mantilla, Maria, Jank, Larissa, Harris, Samantha, Douglas, Morgan, Smith, Matthew D., Calabresi, Peter A., Mowry, Ellen M., Fitzgerald, Kathryn C., Bhargava, Pavan

“…Sphingosine-1-phosphate receptor (S1P) modulators and anti-CD20 therapies impair humoral responses to SARS-CoV-2 mRNA vaccines. Relatively few studies have…”
Get full text

Emerging Concepts on the Gut Microbiome and Multiple Sclerosis by Glenn, Justin D, Mowry, Ellen M

“…Microbiota of the human body perform fundamental tasks that contribute to normal development, health, and homeostasis and are intimately associated with…”
Get more information

Harnessing Real-World Data to Inform Decision-Making: Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) by Mowry, Ellen M, Bermel, Robert A, Williams, James R, Benzinger, Tammie L S, de Moor, Carl, Fisher, Elizabeth, Hersh, Carrie M, Hyland, Megan H, Izbudak, Izlem, Jones, Stephen E, Kieseier, Bernd C, Kitzler, Hagen H, Krupp, Lauren, Lui, Yvonne W, Montalban, Xavier, Naismith, Robert T, Nicholas, Jacqueline A, Pellegrini, Fabio, Rovira, Alex, Schulze, Maximilian, Tackenberg, Björn, Tintore, Mar, Tivarus, Madalina E, Ziemssen, Tjalf, Rudick, Richard A

“…Multiple Sclerosis Partners Advancing Technology and Health Solutions (MS PATHS) is the first example of a learning health system in multiple sclerosis (MS)…”
Get full text

Intermittent calorie restriction alters T cell subsets and metabolic markers in people with multiple sclerosis by Fitzgerald, Kathryn C., Bhargava, Pavan, Smith, Matthew D., Vizthum, Diane, Henry-Barron, Bobbie, Kornberg, Michael D., Cassard, Sandra D., Kapogiannis, Dimitrios, Sullivan, Patrick, Baer, David J., Calabresi, Peter A., Mowry, Ellen M.

“…Intermittent fasting or calorie restriction (CR) diets provide anti-inflammatory and neuroprotective advantages in models of multiple sclerosis (MS); data in…”
Get full text

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis by Sotirchos, Elias S, Gonzalez-Caldito, Natalia, Dewey, Blake E, Fitzgerald, Kathryn C, Glaister, Jeffrey, Filippatou, Angeliki, Ogbuokiri, Esther, Feldman, Sydney, Kwakyi, Ohemaa, Risher, Hunter, Crainiceanu, Ciprian, Pham, Dzung L, Van Zijl, Peter C, Mowry, Ellen M, Reich, Daniel S, Prince, Jerry L, Calabresi, Peter A, Saidha, Shiv

“…Background: The effects of disease-modifying therapies (DMTs) on region-specific brain atrophy in multiple sclerosis (MS) are unclear. Objective: To determine…”
Get full text

Peripheral T-Cells, B-Cells, and Monocytes from Multiple Sclerosis Patients Supplemented with High-Dose Vitamin D Show Distinct Changes in Gene Expression Profiles by Kim, Dohyup, Witt, Emily E, Schubert, Simone, Sotirchos, Elias, Bhargava, Pavan, Mowry, Ellen M, Sachs, Karen, Bilen, Biter, Steinman, Lawrence, Awani, Avni, He, Zihuai, Calabresi, Peter A, Van Haren, Keith

“…Vitamin D is a steroid hormone that has been widely studied as a potential therapy for multiple sclerosis and other inflammatory disorders. Pre-clinical…”
Get full text

Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism by Fitzgerald, Kathryn C., Smith, Matthew D., Kim, Sol, Sotirchos, Elias S., Kornberg, Michael D., Douglas, Morgan, Nourbakhsh, Bardia, Graves, Jennifer, Rattan, Ramandeep, Poisson, Laila, Cerghet, Mirela, Mowry, Ellen M., Waubant, Emmanuelle, Giri, Shailendra, Calabresi, Peter A., Bhargava, Pavan

“…The circulating metabolome provides unique insights into multiple sclerosis (MS) pathophysiology, but existing studies are relatively small or characterized…”
Get full text

Multiple sclerosis susceptibility genes: associations with relapse severity and recovery by Mowry, Ellen M, Carey, Robert F, Blasco, Maria R, Pelletier, Jean, Duquette, Pierre, Villoslada, Pablo, Malikova, Irina, Roger, Elaine, Kinkel, R Phillip, McDonald, Jamie, Bacchetti, Peter, Waubant, Emmanuelle

“…Patients with early multiple sclerosis (MS) have stereotyped attack severity and recovery. We sought to determine if polymorphisms in MS susceptibility genes…”
Get full text

Associations of sNfL with clinico‐radiological measures in a large MS population by Sotirchos, Elias S., Fitzgerald, Kathryn C., Singh, Carol M., Smith, Matthew D., Reyes‐Mantilla, Maria, Hersh, Carrie M., Hyland, Megan H., Canissario, Ryan, Simmons, Sarah B., Arrambide, Georgina, Montalban, Xavier, Comabella, Manuel, Naismith, Robert T., Qiao, Min, Krupp, Lauren B., Nicholas, Jacqueline A., Akgün, Katja, Ziemssen, Tjalf, Rudick, Richard, Fisher, Elizabeth, Bermel, Robert A., Mowry, Ellen M., Calabresi, Peter A.

“…Objective Evaluation of serum neurofilament light chain (sNfL), measured using high‐throughput assays on widely accessible platforms in large, real‐world MS…”
Get full text

Neuromyelitis optica unmasked by a spinal dural arteriovenous fistula by Freund, Brin, MD, Mowry, Ellen M., MD, MCR, Levy, Michael, MD, PhD, Newsome, Scott D., DO

“…A bstract Neuromyelitis optica spectrum disorder (NMO-SD) and spinal dural arteriovenous fistula (SDAVF) can both cause longitudinally extensive myelopathy. We…”
Get full text

Natural History of Multiple Sclerosis: Early Prognostic Factors by Mowry, Ellen M., MD, MCR

“…Multiple sclerosis is a heterogeneous disease, and predicting its course is difficult at the individual level. In this article, clinical, demographic, and…”
Get full text

Switching multiple sclerosis patients with breakthrough disease to second-line therapy by Castillo-Trivino, Tamara, Mowry, Ellen M, Gajofatto, Alberto, Chabas, Dorothee, Crabtree-Hartman, Elizabeth, Cree, Bruce A, Goodin, Douglas S, Green, Ari J, Okuda, Darin T, Pelletier, Daniel, Zamvil, Scott S, Vittinghoff, Eric, Waubant, Emmanuelle

“…Multiple sclerosis (MS) patients with breakthrough disease on immunomodulatory drugs are frequently offered to switch to natalizumab or immunosuppressants. The…”
Get full text

Vitamin D status and latitude predict brain lesions in adrenoleukodystrophy by Keith P. vanHaren, Jacob Wilkes, Ann B. Moser, Gerald V. Raymond, Troy Richardson, Patrick Aubourg, Timothy W. Collins, Ellen M. Mowry, Joshua L. Bonkowsky

“…Abstract Objectives Approximately 40% of boys with X‐linked adrenoleukodystrophy (ALD) develop inflammatory demyelinating brain lesions (cerebral ALD, cALD)…”
Get full text

Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis by Waubant, Emmanuelle, Mowry, Ellen M, Krupp, Lauren, Chitnis, Tanuja, Yeh, E Ann, Kuntz, Nancy, Ness, Jayne, Belman, Anita, Milazzo, Maria, Gorman, Mark, Weinstock-Guttman, Bianca, Rodriguez, Moses, James, Judith A

“…Background: As remote infections with common herpes viruses are associated with modulation of the risk of multiple sclerosis (MS), we hypothesized that…”
Get full text

Early Aggressive Treatment Approaches for Multiple Sclerosis by Simpson, Alexandra, Mowry, Ellen M., Newsome, Scott D.

“…Purpose of review This review presents a comprehensive analysis of the current high-efficacy disease-modifying therapies (DMTs) available for treatment of…”
Get full text